Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
ZOLPIDEM TARTRATE TABLETS. These highlights do not include all the information needed to use ZOLPIDEM TARTRATE TABLETS safely and effectively. See full prescribing information for ZOLPIDEM TARTRATE TABLETS. ZOLPIDEM TARTRATE tablets, for oral use, CIV Initial U.S. Approval: 1992
Medication labelWhy this: Advisory · dailymed-prescription
Zolpidem Tartrate Tablets is indicated for the short-term treatment of insomnia characterized by difficulties with sleep initiation. Zolpidem Tartrate Tablets has been shown to decrease sleep latency for up to 35 days in controlled clinical studies [see Clinical Studies ( 14)]. The clinical trials performed in support of efficacy were 4–5 weeks in duration with the final formal assessments of sleep latency performed at the end of treatment.
- generic_name
- zolpidem tartrate
- product_names
- Zolpidem Tartrate
- ndc
- 71610-847, 51407-877, 71610-847-15, 71610-847-20, 71610-847-21, 71610-847-28, 71610-847-30, 71610-847-45, 71610-847-53, 71610-847-60, 71610-847-10, 71610-847-14
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en